Skip to main content
Home
About Us
Market
Management
Management
Board of Directors
Investor Relations
News
Stock Information
Stock Quote
Historical Stock Quote
Investment Calculator
SEC Filings
Corporate Governance
Governance Documents
Board of Directors
Shareholder Services
Investor FAQs
Investor Emails Alerts
Investor Contact
Contact Us
Site Search
News
Home
About Us
Market
Management
Management
Board of Directors
Investor Relations
News
Stock Information
Stock Quote
Historical Stock Quote
Investment Calculator
SEC Filings
Corporate Governance
Governance Documents
Board of Directors
Shareholder Services
Investor FAQs
Investor Emails Alerts
Investor Contact
Contact Us
Home
About Us
Market
Management
Management
Board of Directors
Investor Relations
News
Stock Information
Stock Quote
Historical Stock Quote
Investment Calculator
SEC Filings
Corporate Governance
Governance Documents
Board of Directors
Shareholder Services
Investor FAQs
Investor Emails Alerts
Investor Contact
Contact Us
Normal
Press release year list
2024
2023
2022
2021
2020
12/01/2023
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
11/13/2023
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update
08/14/2023
Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
08/01/2023
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
05/19/2023
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
05/15/2023
Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update
03/31/2023
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update
01/12/2023
Mr. David Gryska Appointed to Forte Biosciences Board of Directors